<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7091034\results\search\drug\results.xml">
  <result pre="that Avian influenza viruses preferentially bind to sialic acids via" exact="alpha" post="2,3 linkages present on alveolar type II cells and"/>
  <result pre="to NAAT tests. Treatment The neuroaminase inhibitors like Oseltamivir and" exact="Zanamivir" post="are the mainstay for treatment and help to inhibit"/>
  <result pre="patients with Oseltamivir resistance who develop infection. The alternative antiviral," exact="Zanamivir" post="given by inhalation is approved for age more than"/>
  <result pre="given in those with underlying airway disease. The older antivirals," exact="Amantidine" post="and Rimatidine are no longer recommended since 2006 due"/>
  <result pre="have the potential to cause pandemic [22]. Two intravenous NIs," exact="Peramivir" post="and Zanamivir, are currently undergoing clinical trials [19]. Laninamivir"/>
  <result pre="oral Oseltamivir (for above 3 mo of age) or inhaled" exact="Zanamivir" post="(for above 7 y of age) is recommended for"/>
 </snippets>
</snippetsTree>
